Repligen Balance Sheet Health
Financial Health criteria checks 4/6
Repligen has a total shareholder equity of $2.0B and total debt of $579.6M, which brings its debt-to-equity ratio to 29.4%. Its total assets and total liabilities are $2.8B and $853.2M respectively. Repligen's EBIT is $56.2M making its interest coverage ratio -4. It has cash and short-term investments of $751.3M.
Key information
29.4%
Debt to equity ratio
US$579.60m
Debt
Interest coverage ratio | -4x |
Cash | US$751.32m |
Equity | US$1.97b |
Total liabilities | US$853.21m |
Total assets | US$2.82b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: R2GE34's short term assets ($1.1B) exceed its short term liabilities ($158.2M).
Long Term Liabilities: R2GE34's short term assets ($1.1B) exceed its long term liabilities ($695.0M).
Debt to Equity History and Analysis
Debt Level: R2GE34 has more cash than its total debt.
Reducing Debt: R2GE34's debt to equity ratio has increased from 16.8% to 29.4% over the past 5 years.
Debt Coverage: R2GE34's debt is not well covered by operating cash flow (19.7%).
Interest Coverage: R2GE34 earns more interest than it pays, so coverage of interest payments is not a concern.